Faculty

Zwelithini Tunyiswa

BA
Director and Co-Founder
Open Wound Research

Zwelithini "Zweli" Tunyiswa is the founder and CEO of Open Wound Research, where he leads Bayesian statistics, randomized controlled trials, and real-world evidence studies in chronic wound care. His research spans advanced wound-care modalities, wound-associated pain, and nutrition in healing, and includes a Bayesian hierarchical meta-analysis of the trials underpinning Medicare's 2024 Local Coverage Determinations and statistical analyses of multicenter trials in diabetic foot, venous leg, and pressure ulcers. He and his team at Open Wound Research built the LiftOff and BaseCamp registries to advance real-world evidence in wound care. His scholarship covers wound-care research methodology, Bayesian methods for economic and lifetime analyses, and real-world evidence for regulatory and reimbursement decisions.

Mr. Tunyiswa serves on the Editorial Board of Chronic Wound Care Management and Research, on the Research Board of the Association for the Advancement of Wound Care (AAWC), and chairs the Clinical Trial Standards & Reporting Workstream of the Wound Care Collaborative Community (WCCC). He hosts the Open Wound Research Podcast and is the co-architect of the CONSORT 2025 Flowchart Generator and the WoundStats community forum. He speaks regularly at major wound-care meetings. Through the Bexia project, he has built an international research network linking U.S. clinicians with leading South African wound-care specialists. He holds a degree from the University of Pennsylvania.

2026 Sessions

Mobile Wound Management: Compliance and Risk: Staying Legal on the Road (developed in collaboration with PAWSIC)

Compliance in mobile wound care extends far beyond the clinic—and understanding what is and isn’t permitted across different points of service (POS) is essential. This session focuses on the distinct legal and regulatory challenges faced by mobile providers, including HIPAA, OSHA, CMS, and payer-specific requirements unique to care delivered on the move. Faculty will outline practical strategies for maintaining compliant documentation, accurate coding, and audit-ready records while safeguarding patient privacy and provider safety in dynamic, real-world environments.

Co-Presenter

Moderator/Presenter

Friday, October 16 11:00–12:00 PM
Room Milano 1
Mobile Wound Management
Faculty

Julie Rhodovi

MBA, CWCA, LBBH
Consultant
GHH Advisors, LLC

Julie Rhodovi is an accomplished, senior executive level professional, with health care strategy development, revenue cycle, payor and government relations, and contract relations experience. Her experience includes managing contract negotiations, field-based services, oversight of the cross-functional network service experience, and working with interdisciplinary management teams across the country to determine needed relations with payor organizations. She has worked in the post-acute care setting and the payor field for over 30 years, with direct experience in the building and launching of a Medicare Advantage plan. Throughout the past 20 years, Julie's direct focus has been in the wound care space of post-acute care, with specific concentration on the regulations and coverage.
Ms. Rhodovi is a Certified Wound Care Associate (CWCA) with the American Board of Wound Management (ABWM) and the current treasurer with the ABWM Foundation, as a Board of Trustee. She is a founding executive member and treasurer of the Post-Acute Wound and Skin Integrity Council (PAWSIC) and a Board Member on the Alliance of Wound Care Stakeholders. Ms. Rhodovi holds a master’s in business administration with a concentration in health management and is a certified six sigma lean black belt in healthcare (LBBH).

Faculty

Zwelithini Tunyiswa

BA
Director and Co-Founder
Open Wound Research

Zwelithini "Zweli" Tunyiswa is the founder and CEO of Open Wound Research, where he leads Bayesian statistics, randomized controlled trials, and real-world evidence studies in chronic wound care. His research spans advanced wound-care modalities, wound-associated pain, and nutrition in healing, and includes a Bayesian hierarchical meta-analysis of the trials underpinning Medicare's 2024 Local Coverage Determinations and statistical analyses of multicenter trials in diabetic foot, venous leg, and pressure ulcers. He and his team at Open Wound Research built the LiftOff and BaseCamp registries to advance real-world evidence in wound care. His scholarship covers wound-care research methodology, Bayesian methods for economic and lifetime analyses, and real-world evidence for regulatory and reimbursement decisions.

Mr. Tunyiswa serves on the Editorial Board of Chronic Wound Care Management and Research, on the Research Board of the Association for the Advancement of Wound Care (AAWC), and chairs the Clinical Trial Standards & Reporting Workstream of the Wound Care Collaborative Community (WCCC). He hosts the Open Wound Research Podcast and is the co-architect of the CONSORT 2025 Flowchart Generator and the WoundStats community forum. He speaks regularly at major wound-care meetings. Through the Bexia project, he has built an international research network linking U.S. clinicians with leading South African wound-care specialists. He holds a degree from the University of Pennsylvania.

Faculty

Jeanine Maguire

PhD, MS, MPT, FAAC, CWS
President, PAWSIC; SeekingWhole, LLC
PAWSIC

Jeanine Maguire, a Physical Therapist and Certified Wound Specialist is a visionary leader and PhD scholar dedicated to connecting and building high-performing teams to dramatically improve health care and patient outcomes. With nearly three decades in wound management, Dr. Maguire previously held the impactful role of VP of Skin Health and Wound Management Integrations at Genesis HealthCare, managing a program that scaled technology and standardized care across 500 nursing homes nationwide. Her innovative spirit led her to serve as a Chief Clinical Delivery Officer for a Value Based Care Wound Start-up, where she was a pioneer in building sophisticated care pathways and collaborating with AI engineers to develop evidence-based clinical guidance rules. Her commitment to integrated, patient-centered care culminated in her role as President and co-founder of the rising global non-profit, the Post-Acute Wound Skin Integrity Council (PAWSIC), driving advocacy and educational excellence across the post-acute sector and beyond.

Navigating the Use of CAMPS in 2026

This session will provide forward-looking insights into the evolving use of cellular, acellular, and matrix-based products (CAMPS) in wound care as we approach 2026. Faculty will discuss recent regulatory updates, new product innovations, and evolving clinical evidence guiding appropriate selection and application. attendees will gain a strategic understanding of how to navigate the expanding CAMPS landscape to optimize healing outcomes and ensure cost-effective, evidence-based care.

Co-Presenter

Moderator/Presenter

Saturday, October 17 9:15–10:15 AM
Room Octavius 7
Faculty

Arati Bhosale

MD, MPH
Global Director of Regulatory Affairs
Serena Groups Inc.

Arati Bhosale (Dr.B)-Global Director of Regulatory Affairs, Serena Groups Inc.
Arati Bhosale is a globally recognized healthcare innovator and the Global Director of Regulatory Affairs at Serena Groups Inc., bringing over 17 years of expertise at the intersection of clinical research, regulatory strategy, and health technology. Her career has been defined by a singular mission-transforming rigorous science into real-world patient impact, at scale.
Arati has led and optimized clinical trial operations across multiple phases and international markets, navigating complex regulatory frameworks including FDA, EMA/MDR, and ICH guidelines with both precision and agility. In the wound care space, her regulatory acumen and operational discipline translate directly into accelerating therapy development, ensuring compliance, and improving patient outcomes without sacrificing speed or quality.
A visionary in HealthTech, Arati has built AI-driven platforms designed to streamline clinical workflows and turn complex datasets into confident, actionable decisions. She is equally at home in regulatory discussions, product strategy sessions, and clinical education forums-a communicator who bridges science, technology, and human behavior with clarity.
At this conference, Arati presents as a leading regulatory voice on the evolving landscape of CAMP wound products; offering expert perspective on the strategic pivot, compliance pathways, and regulatory future that will define how these therapies reach, and transform patient care.

Faculty

Zwelithini Tunyiswa

BA
Director and Co-Founder
Open Wound Research

Zwelithini "Zweli" Tunyiswa is the founder and CEO of Open Wound Research, where he leads Bayesian statistics, randomized controlled trials, and real-world evidence studies in chronic wound care. His research spans advanced wound-care modalities, wound-associated pain, and nutrition in healing, and includes a Bayesian hierarchical meta-analysis of the trials underpinning Medicare's 2024 Local Coverage Determinations and statistical analyses of multicenter trials in diabetic foot, venous leg, and pressure ulcers. He and his team at Open Wound Research built the LiftOff and BaseCamp registries to advance real-world evidence in wound care. His scholarship covers wound-care research methodology, Bayesian methods for economic and lifetime analyses, and real-world evidence for regulatory and reimbursement decisions.

Mr. Tunyiswa serves on the Editorial Board of Chronic Wound Care Management and Research, on the Research Board of the Association for the Advancement of Wound Care (AAWC), and chairs the Clinical Trial Standards & Reporting Workstream of the Wound Care Collaborative Community (WCCC). He hosts the Open Wound Research Podcast and is the co-architect of the CONSORT 2025 Flowchart Generator and the WoundStats community forum. He speaks regularly at major wound-care meetings. Through the Bexia project, he has built an international research network linking U.S. clinicians with leading South African wound-care specialists. He holds a degree from the University of Pennsylvania.

Faculty

Thomas Serena

MD FACS
CEO and Medical Director
SerenaGroup, Inc.

Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a physician-owned contract research organization (CRO) that conducts clinical trials in a broad range of diseases related to wound healing. To promote clinical research in the burgeoning field of wound care, SerenaGroup® established a site management organization (SMO) that assists hospitals and clinics in establishing compliant research programs. In addition, SerenaGroup® provides consulting services for advanced wound and hyperbaric centers across the globe. Dr. Serena completed his residency in Surgery at Penn State and maintains board certification in Surgery.

Dr. Serena operates advanced wound care and research centers across the United Sates and globally. He has been the lead or Principal investigator in over 150 clinical trials, including diagnostics, antimicrobial dressings, growth factors, and CAMP therapy. He is one of the world leaders in clinical research, quality improvement, and real-world data collection. He holds numerous patents on wound care devices and dressings.
He is recognized internationally as an expert in the field of wound healing: He has more than 350 published papers and has given more than 2500 invited lectures throughout the world. He has been a member of the Board of Directors of the Wound Healing Society He is a Past President of the Association for the Advancement of Wound Care (AAWC) and American Professional Wound Care Association. He is the Vice-President of the International Surgical Wound Complication Advisory Board (ISWCAP). In 2024, he founded the international Post-Acute Wound Society (iPAWS).
.

Back to top